4.6 Article

Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection

期刊

PLOS ONE
卷 17, 期 6, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0270130

关键词

-

资金

  1. National key R&D Program Drug Resistance Database Construction and Ecological Risk Assessment in Livestock and Poultry Breeding Environment [2016YFD0501305]
  2. Innovation Project of Chinese Academy of Agricultural Sciences [CAASFRI-06]

向作者/读者索取更多资源

This study aimed to investigate the pharmacokinetic parameters of imidocarb in cattle and evaluate the bioequivalence of two imidocarb formulations. The results showed that the pharmacokinetic profiles of the two formulations were similar, leading to the conclusion that they are bioequivalent in cattle.
Imidocarb (IMD) is commonly used for treatment of eperythrozoon, babesia, piroplasma and trypanosoma in animals, but there are few studies on its pharmacokinetics in cattle. The purpose of this study was to obtain pharmacokinetic parameters and assess the bioequivalence of subcutaneous injections of two IMD formulations in cattle. Forty-eight healthy cattle, 24 males and 24 females, were randomLy divided into two groups (test group and reference group) with 12 males and 12 females per group. The generic IMD was injected subcutaneously with a single dose of 3.0 mg/kg in the test group. Reference group animals were given one injection of the marketed IMD at the same dosage. The limit of detection (LOD) and limit of quantification (LOQ) for IMD in cattle plasma were 0.05 ng/mL and 0.1 ng/mL, respectively. The recoveries ranged from 88.50% to 92.42%, and the equation of this calibration curve was Y = 13672.1X+187.43. The pharmacokinetics parameters of the test group showed that the maximum concentration of 2257.5 +/- 273.62 ng/mL was obtained at 2.14 +/- 0.67 h, AUC(0-t) 14553.95 +/- 1946.85 ng.h/mL, AUC(infinity) 15077.88 +/- 1952.19 ng.h/mL, T-1/2 31.77 +/- 25.75 h, CL/F 0.14 +/- 0.02 mL/h/g, and V-z/F 6.53 +/- 5.34 mL/g. There was no significant difference in AUC(0-t), AUC(infinity) and C-max between the test group and the reference group (P>0.05). The 90% confidence interval of AUC(0-t), AUC(0-infinity) and C-max in the test group was included in 80%-125% AUC(0-t), AUC(0-infinity) and 70%-143% C-max in the reference group, respectively. Based on these results, the two preparations were found to be bioequivalent.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据